Increased MAL2 levels in breast cancer cell lines favored the formation of signaling complexes with the transmembrane tyrosine kinase receptor HER2 in membrane protrusions (Figure 6D), contributing to the persistence of activated HER2 on the plasma membrane [147]. This evidence concerns the gene MAL2 and breast carcinoma.